While STAT1 inhibition yielded mixed results without statistical significance (Supplementary Figure S9) in 10 T2DM patients, pSTAT3 inhibition produced similar reductions in pro-inflammatory cytokines as observed with TNF-α inhibition. The gene discussed is STAT1; the disease is type 2 diabetes mellitus.